Topic: Atherosclerosis, Secondary CVD Prevention
Featured Expert: Peter Libby, MD and Paul Ridker, MD
Drs. Libby and Ridker address CHD risk factors beyond lipids by presenting their research on the role of inflammation in the pathophysiology of atherosclerosis and the impact anti-inflammatory therapies under investigation may have on reducing cardiovascular event rates.
View Video 1 View Video 2